Article

Severe Rashes Associated With Immunotherapy and Gene Mutations in a Patient With Metastatic Pancreatic Cancer

2022-02-22

Abstract excerpt

<h4>Background: </h4> Pancreatic cancer is a high-risk malignant tumor, and is traditionally treated with chemotherapy. However, the curative effect of traditional treatment is very poor, and new treatment methods are being explored. Sintilimab is a fully human IgG4 monoclonal antibody; it can bind to PD-1, block the interaction of PD-1 with its ligands, and can improve the survival of cancer patients. Case presen...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8a11585b-a3ba-5e94-af0b-8b9651577ea7
DOI: 10.21203/rs.3.rs-1374816/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Severe Rashes Associated With Immunotherapy and Gene Mutations in a Patient With Metastatic Pancreatic CancerDOI 10.21203/rs.3.rs-1374816/v1Read

Successful Immunotherapy for Pancreatic Cancer in a Patient With TSC2 and SMAD4 Mutations: A Case Report.Semantic proximity Read

Unexpected favorable outcome to sintilimab monotherapy in a relapse pancreatic ductal adenocarcinoma patient with high tumor mutational burden: a case report.Semantic proximity Read

First Reported Advanced Pancreatic Cancer With Hyperprogression Treated With PD-1 Blockade combined with chemotherapy: A Case Report And Literature ReviewSemantic proximity Read

Erlotinib-induced skin rash. Pathogenesis, clinical significance and management in pancreatic cancer patients.Semantic proximity Read

PD-1 blockade plus capecitabine as curative-intent treatment for tumor mutational burden-high multi-metastatic pancreatic ductal adenocarcinoma: A case reportSemantic proximity Read

Immune Checkpoint Inhibitors-Related Thyroid Dysfunction: Epidemiology, Clinical Presentation, Possible Pathogenesis, and Management.Semantic proximity Read

Immunotherapy Combined with Chemotherapy versus Chemotherapy Alone in Advanced Pancreatic Ductal Adenocarcinoma: a Real-world Retrospective Cohort StudySemantic proximity Read

Case report: Targeting the PD-1 receptor and genetic mutations validated in primary histiocytic sarcoma with hemophagocytic lymphohistiocytosis.Semantic proximity Read

Aplastic Anemia Secondary to Dual Cancer Immunotherapies A Physician Nightmare: Case Report and Literature ReviewSemantic proximity Read

Targeting tumor tolerance: A new hope for pancreatic cancer therapy?Semantic proximity Read

Laminin γ2–mediating T cell exclusion attenuates response to anti–PD-1 therapySemantic proximity Read

Exceptional Response to Olaparib and Pembrolizumab for Pancreatic Adenocarcinoma With Germline BRCA1 Mutation and High Tumor Mutation Burden: Case Report and Literature Review.Semantic proximity Read